Levetiracetam inhibits glutamate transmission through presynaptic P/Q‐type calcium channels on the granule cells of the dentate gyrus

作者: Chun-Yao Lee , Chih-Chuan Chen , Horng-Huei Liou

DOI: 10.1111/J.1476-5381.2009.00463.X

关键词: LevetiracetamNeuroscienceVoltage-dependent calcium channelAMPA receptorP-type calcium channelNMDA receptorDentate gyrusCalcium channelExcitatory postsynaptic potentialChemistryPharmacology

摘要: Background and purpose:  Levetiracetam is an effective anti-epileptic drug in the treatment of partial generalized seizure. The purpose present study was to investigate whether levetiracetam regulates AMPA NMDA receptor-mediated excitatory synaptic transmission determine its site action dentate gyrus (DG), area hippocampus that seizure activities. Experimental approach:  Whole-cell patch-clamp method used record postsynaptic currents (EPSCAMPA EPSCNMDA) presence specific antagonists, from granule cells DG brain slice preparations young Wistar rats (60–120 g). Key results:  (100 µM) inhibited both evoked EPSCAMPA EPSCNMDA equal extent (80%), altered paired-pulse ratio (from 1.39 1.25), decreased frequency asynchronous EPSC prolonged inter-event interval miniature 2.7 4.6 s) without changing amplitude, suggesting a presynaptic levetiracetam. inhibitory effect on blocked by ω-agatoxin TK (100 nM), selective P/Q-type voltage-dependent calcium channel blocker, but not nimodipine (10 µM) or ω-conotoxin (400 nM). Conclusions implications:  These results suggest modulated reduce glutamate release amplitude DG. This most likely contribute patients.

参考文章(43)
P.N. Patsalos, Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacology & Therapeutics. ,vol. 85, pp. 77- 85 ,(2000) , 10.1016/S0163-7258(99)00052-2
Ann Marie Craig, Hélène Boudin, Molecular heterogeneity of central synapses: afferent and target regulation Nature Neuroscience. ,vol. 4, pp. 569- 578 ,(2001) , 10.1038/88388
Dagmar Hönack, Wolfgang Löscher, Chris Rundfeldt, Antiepileptogenic Effects of the Novel Anticonvulsant Levetiracetam (ucb L059) in the Kindling Model of Temporal Lobe Epilepsy Journal of Pharmacology and Experimental Therapeutics. ,vol. 284, pp. 474- 479 ,(1998)
Nancy W. Kleckner, Jill C. Glazewski, Chi Chiung Chen, Tammy D. Moscrip, Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action. Journal of Pharmacology and Experimental Therapeutics. ,vol. 289, pp. 886- 894 ,(1999)
Alessandro Stefani, Francesca Spadoni, Antonio Siniscalchi, Giorgio Bernardi, Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications European Journal of Pharmacology. ,vol. 307, pp. 113- 116 ,(1996) , 10.1016/0014-2999(96)00265-8
S Ozawa, GLUTAMATE RECEPTORS IN THE MAMMALIAN CENTRAL NERVOUS SYSTEM Progress in Neurobiology. ,vol. 54, pp. 581- 618 ,(1998) , 10.1016/S0301-0082(97)00085-3
Antonio Pisani, Paola Bonsi, Giuseppina Martella, Cristiano De Persis, Cinzia Costa, Francesco Pisani, Giorgio Bernardi, Paolo Calabresi, Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. Epilepsia. ,vol. 45, pp. 719- 728 ,(2004) , 10.1111/J.0013-9580.2004.02204.X
Isabelle Niespodziany, Henrik Klitgaard, Doru Georg Margineanu, Levetiracetam inhibits the high-voltage-activated Ca2+ current in pyramidal neurones of rat hippocampal slices Neuroscience Letters. ,vol. 306, pp. 5- 8 ,(2001) , 10.1016/S0304-3940(01)01884-5
Ali Gorji, Jorg‐Michael Höhling, Michael Madeja, Heidrun Straub, Rüdiger Köhling, Ingrid Tuxhorn, Alois Ebner, Peter Wolf, H. W. Panneck, F. Behne, Rainer Lahl, Erwin‐Joseph Speckmann, Effect of levetiracetam on epileptiform discharges in human neocortical slices. Epilepsia. ,vol. 43, pp. 1480- 1487 ,(2002) , 10.1046/J.1528-1157.2002.23702.X
Chien-Hsing Lee, Chun-Yao Lee, Ting-Shan Tsai, Horng-Huei Liou, PKA-mediated phosphorylation is a novel mechanism for levetiracetam, an antiepileptic drug, activating ROMK1 channels Biochemical Pharmacology. ,vol. 76, pp. 225- 235 ,(2008) , 10.1016/J.BCP.2008.04.012